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Letters

The sensitivity analysis that included individuals with diabetes mellitus as secondary prevention did not alter the patterns seen in Figure, A), but there was a decrease in primary
prevention use to 30.3% (95% CI, 26.4%-34.4%) in 2011 to 2012.
Discussion | One-third of community-dwelling very elderly individuals without vascular disease reported a statin prescription despite a lack of randomized clinical trials to support their
use.1,2 Despite a lack of clear recommendation for statin use
in the primary prevention of the very elderly within the Adult
Treatment Panel III guideline,6 there was a large increase in
use that coincided with its release. The primary limitation of
our study is the change in the classification of vascular disease, which likely increased the sensitivity and decreased the
specificity of vascular disease. Hence, the classification of primary prevention likely became more conservative. Although
the medical community has embraced the use of statins for primary prevention in the very elderly, caution should be exercised given the potential dangers of expanding marginally effective treatments to untested populations.
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Rates of Kidney Transplantation From Living
and Deceased Donors for Blacks and Whites
in the United States, 1998 to 2011
Kidney transplantation, the treatment standard for patients
with end-stage renal disease (ESRD), is associated with prolonged survival, improved quality of life, reduced morbidity,
and lower health care costs compared with dialysis.1 Racial disparities in kidney transplantation are well documented; studies show that black patients are less likely than white patients
to be referred for transplant evaluation, registered for transplantation, progress through the waiting list, and ultimately
receive a transplant.2 The effects of ongoing efforts to eliminate these disparities are uncertain.3 We used data from the
United Network of Organ Sharing (UNOS) registry to examine
current patterns of racial disparities in kidney transplantation. To focus on the decision to refer patients for transplantation, we used patients with ESRD as the denominator, not
patients on the transplant waiting list.
Methods | To identify transplant recipients and living donors,
we queried the UNOS data registry (1998 to 2011). We
obtained data on the incidence of ESRD, stratified by race,
from the United States Renal Data System and calculated
temporal trends in kidney transplantation (per 1000 patients
with ESRD) for all transplant recipients and separately for
those with deceased and living donors. We adjusted the
trends for age, sex, ESRD cause, and geographic region using
the direct-iterative adjustment method4 and reported the
adjusted trends using the estimated annual percent change
methodology.
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Results | Between 1998 and 2011, 184 303 patients, 13.5% of the
1 355 671 patients with ESRD in the United States Renal Data
System, underwent kidney transplantation. Of these patients, 37.1% (n = 68 381) underwent living donor transplantation. Figure 1 shows that the incidence of kidney transplantation in black patients increased at an annual rate of 2.84%
from 93 per 1000 patients with ESRD in 1998 to 128 per 1000
in 2011 (95% CI, +2.32% to +3.41%; P < .001). Thus, by 2010,
the incidence of kidney transplantation for black and white patients was equivalent.
In whites, the rate of transplantation from deceased donors declined between 1998 and 2011 (estimated annual percent change, −1.66%; 95% CI, −2.11% to −1.20%; P < .001), while
the rate of transplantation from living donors was unchanged (estimated annual percent change −1.05%; 95% CI,
−2.33% to +0.24%; P = .14) (Figure 2A). For black patients, the
rate of kidney transplantation from deceased donors increased (estimated annual percent change, +3.49%; 95% CI,
+2.81% to +4.29%; P < .001), while the rate of transplantation from living donors was unchanged (estimated annual percent change, +0.14%; 95% CI, −1.73% to +2.01%; P = .88)
(Figure 2B). Over the study period, the percentages of kidney
transplants from living donors were 43.2% for white patients
and 22.2% for black patients. Of live kidney donations, 15.5%
were from black donors; the rate remained stable (estimated
annual percent change, −0.78%; 95% CI, −2.53% to +1.21%;
P = .45).
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Figure 1. Incidence of Kidney Transplantation in Black and White
Recipients Between 1998 and 2011
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The incidence was adjusted for age, sex, end-stage renal disease (ESRD) cause,
and geographic region.

Figure 2. Incidence by Donor Status of Kidney Transplantation in Black
and White Recipients Between 1998 and 2011
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ney transplantation was the same for blacks and whites; this
change was driven wholly by increased rates of transplants
from deceased donors.
Kidney transplants from living donors are associated
with better outcomes than transplants from deceased
donors. 6 The persistence of lower rates of living donors
among blacks limits access to the best possible transplant
outcomes. Lower donation rates have been attributed to differences in socioeconomic status, personal attitudes toward
transplantation, fear of surgery, and health literacy.1,4 The
higher prevalence of comorbid conditions among potential
black donors, such as hypertension and diabetes, may also
preclude organ donation.1 Approaches to increasing living
donor kidney transplantation rates include outreach and
educational programs, better patient-physician communication, and counseling of black patients with ESRD and their
families. Such measures, if effective, hold potential for
expanding the overall donor pool, thus improving care for
all patients with ESRD.
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Discussion | In 2003, UNOS changed the allocation policy for kidneys from deceased donors by eliminating priority points for
HLA-B matching.3 Because HLA shows clustering within race,
and whites represent the majority demographic, most deceased donors are white; thus, kidneys from deceased donors are more likely to have favorable HLA matches with white
patients. This policy change has been associated with an attenuation of the racial disparity in deceased donor kidney transplantation from 38% in the 2000-2003 period to 19% from
2006 to 2009.5 We found that by 2010, the overall rate of kidjamainternalmedicine.com
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a sauna session) operates within disease groups; the more severe the disease, the greater the fear of cardiac challenge. Consistent with this reasoning, the association between saunas and
sudden cardiac death was seen in individuals with diabetes
(hazard ratio [HR], 0.27; 95% CI, 0.10-0.68; P < .05) but not
those without (HR, 0.90; 95% CI, 0.73-1.10; P > .05), among
hypertensive (HR, 0.66; 95% CI, 0.45-0.96; P < .05) but not normotensive individuals (HR, 0.96; 95% CI, 0.75-1.23; P > .05),
among patients with cardiovascular disease (HR, 0.72; 95% CI,
0.53-0.96; P < .05) but not their healthy counterparts (HR, 1.01;
95% CI, 0.76-1.33; P > .05) (eFigure 1 in the study by Laukkanen et al1). A more robust finding at reduced risk of reverse
causation bias would be a graded association between number of sauna sessions and mortality in an initially healthy, cardiorespiratory fit population, but this was not observed. We
urge caution against the interpretation that saunas are a major cardiovascular prophylactic.
Mika Kivimäki, PhD
Marianna Virtanen, PhD
Jane E. Ferrie, PhD

COMMENT & RESPONSE

The Link Between Sauna Bathing
and Mortality May Be Noncausal
To the Editor Laukkanen et al1 found a striking inverse relationship between saunas (mean temperature, 79°C [174°F])
and fatal cardiovascular disease in Finnish men. The hazard
of sudden cardiac death was more than 60% lower among
men who reported 4 to 7 sauna sessions per week compared
with those who reported only 1 session. For deaths from
coronary heart disease, cardiovascular disease, and all
causes, the corresponding hazard ratios were 40% to 50%
lower. If these observed associations are causal, the risk
reduction associated with frequent sauna visits would be
comparable to or greater than that for traditional prevention
strategies, such as lipid-lowering and antihypertensive
therapy (risk reduction, 20%-50%).2,3
We would like to highlight 2 noncausal mechanisms potentially contributing to the finding by Laukkanen et al1: confounding and reverse causation bias. First, there is an extraordinarily pervasive association between socioeconomic
circumstances and health, with greater affluence linked to
lower risk.4 Men who reported 4 to 7 sauna sessions a week
probably own a sauna and had the time and resources (ie, wood
or electricity) to heat it frequently, which is possibly not the
case for men who reported 1 sauna session a week. Adjustment for a composite socioeconomic status variable measured once at baseline might be insufficient to eliminate confounding by this socioeconomic difference.
Second, the authors note heart rate increases up to 100
beats/min during sauna sessions at moderate temperatures and
up to 150 beats/min during hotter saunas. Although not an issue for healthy individuals, such a cardiac challenge may feel
uncomfortable for participants with poor cardiorespiratory fitness and pre-existing disease. Simple adjustment for disease
vs no disease may not entirely solve this problem since reverse causation bias (ie, health status affects the likelihood of
1718
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The Link Between Sauna Bathing
and Mortality May Be Noncausal
To the Editor In their recent report, Laukkanen et al1 summarize a 25-year longitudinal study, indicating that regular sauna
bathing (4-7 times per week) is associated with a reduced risk
of cardiovascular diseases and all-cause mortality. We would
like to suggest that regular sauna bathing is an indicator for a
healthy lifestyle. Adopting habits of frequent physical activity, avoiding rich food high in saturated fat, and allowing for
more relaxation and leisure time have been proven to be the
best measures against many diseases and are also associated
with improved health and longevity. Laukkanen et al do not
provide data to explain this observation, but other studies suggest that regular sauna bathing lowers blood pressure, improves endothelial function, increases left ventricular ejec-
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